[Does atrial antipressor natriuretic peptide play a pathophysiological role?]

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Renal Physiology

Context:

• Atrial natriuretic peptide (ANP) is released from the atria in response to changes in atrial pressure, volume, and wall tension.
• Hemodynamic measurements during cardiac catheterization provide a platform for studying ANP release and function.
• New radioenzymatic assays enable precise measurement of ANP in human plasma.

Purpose:

• To investigate the physiological release patterns of ANP in humans.
• To assess the effects of synthetic ANP on natriuresis and peripheral vasodilation.
• To explore the interplay between the ANP system and the renin-angiotensin-aldosterone system.

Summary:

• Human atrial natriuretic peptide (ANP) release is pulsatile and linked to atrial pressure and volume.
• Radioenzymatic assays correlate ANP levels with hemodynamic parameters, atrial pressure, and cardiopulmonary volumes.
• Synthetic ANP infusion induces natriuresis and vasodilation, demonstrating its physiological actions.
• ANP counteracts angiotensin II and influences renin and aldosterone, suggesting a role opposing the renin-angiotensin-aldosterone system.
• Elevated plasma ANP is observed in conditions like low-renin hypertension and heart or renal failure.

Impact:

• The findings suggest ANP plays a physiological role in regulating blood pressure and fluid balance in humans.
• Understanding ANP's function provides insights into cardiovascular and renal pathophysiology.
• While potent effects are not evident, ANP's counter-regulatory actions highlight its importance in maintaining homeostasis.